Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway
- PMID: 34802389
- PMCID: PMC8810070
- DOI: 10.1080/21655979.2021.1977104
Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway
Abstract
Glioblastoma (GBM) is the most lethal type of brain cancer. An increasing number of studies suggest that long non-coding RNAs (lncRNAs) are implicated in tumor progression. LncRNA HOXD-AS2 was reported to be highly expressed in glioma and associated with glioma grade and poor prognosis. However, the molecular mechanism remains to be elucidated. In this study, we first analyzed differentially expressed lncRNAs in glioblastoma using RNA-seq dataset (156 GBM samples and 5 adjacent normal samples in TCGA (Cancer Genome Atlas) and GTEx (Genotype-Tissue Expression) database). HOXD-AS2 was found to be significantly up-regulated in GBM tissues, which was further confirmed in GBM patient tumor samples and GBM cell lines. Silencing HOXD-AS2 inhibited cell proliferation, migration and invasion, and promoted cell apoptosis. We further identified and validated miR-3681-5p as a target of HOXD-AS2, and miR-3681-5p was negatively regulated by HOXD-AS2. By negatively affecting miR-3681-5p, HOXD-AS2 could promote the expression of MALT1 to augment the aggressiveness of GBM cells. miR-3681-5p overexpression or MALT1 knockdown attenuated aggressiveness of GBM cells. Importantly, silencing HOXD-AS2 suppressed tumorigenesis of GBM cells in the xenograft mouse model. Collectively, our study clarified the role of miR-3681-5p/MALT1 axis underlying the oncogenic function of lncRNA HOXD-AS2 in GBM. Future work is required to study the mechanism by which HOXD-AS2 is upregulated in GBM cells, which can provide novel insights into therapeutic intervention for GBM treatment.
Keywords: Glioblastoma; LncRNA HOXD‐AS2; MALT1; miR-3681-5p.
Conflict of interest statement
No potential conflicts of interest was reported by the author(s).
Figures






Similar articles
-
Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.J Exp Clin Cancer Res. 2020 Sep 22;39(1):196. doi: 10.1186/s13046-020-01695-8. J Exp Clin Cancer Res. 2020. PMID: 32962742 Free PMC article.
-
LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.J Cell Mol Med. 2020 Jun;24(11):6362-6372. doi: 10.1111/jcmm.15280. Epub 2020 Apr 22. J Cell Mol Med. 2020. PMID: 32319715 Free PMC article.
-
LncRNA HOXA-AS3 promotes the malignancy of glioblastoma through regulating miR-455-5p/USP3 axis.J Cell Mol Med. 2020 Oct;24(20):11755-11767. doi: 10.1111/jcmm.15788. Epub 2020 Sep 11. J Cell Mol Med. 2020. PMID: 32918360 Free PMC article.
-
Unraveling the noncoding RNA landscape in glioblastoma: from pathogenesis to precision therapeutics.Naunyn Schmiedebergs Arch Pharmacol. 2024 Dec;397(12):9475-9502. doi: 10.1007/s00210-024-03265-7. Epub 2024 Jul 15. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39007929 Review.
-
The functional role of LncRNA HOXA-AS2 in multiple human cancers.Pathol Res Pract. 2025 Feb;266:155795. doi: 10.1016/j.prp.2024.155795. Epub 2024 Dec 24. Pathol Res Pract. 2025. PMID: 39756105 Review.
Cited by
-
HOXD-AS2-STAT3 feedback loop attenuates sensitivity to temozolomide in glioblastoma.CNS Neurosci Ther. 2023 Nov;29(11):3430-3445. doi: 10.1111/cns.14277. Epub 2023 Jun 12. CNS Neurosci Ther. 2023. PMID: 37308741 Free PMC article.
-
Identification of a cellular senescence-related-lncRNA (SRlncRNA) signature to predict the overall survival of glioma patients and the tumor immune microenvironment.Front Genet. 2023 Feb 24;14:1096792. doi: 10.3389/fgene.2023.1096792. eCollection 2023. Front Genet. 2023. PMID: 36911393 Free PMC article.
-
MALT1 protease inhibition restrains glioblastoma progression by reversing tumor-associated macrophage-dependent immunosuppression.bioRxiv [Preprint]. 2024 Sep 27:2024.09.26.614808. doi: 10.1101/2024.09.26.614808. bioRxiv. 2024. PMID: 39386586 Free PMC article. Preprint.
-
LncRNA HOXD-AS2 regulates miR-3681-5p/DCP1A axis to promote the progression of non-small cell lung cancer.J Thorac Dis. 2023 Mar 31;15(3):1289-1301. doi: 10.21037/jtd-23-153. Epub 2023 Mar 27. J Thorac Dis. 2023. PMID: 37065560 Free PMC article.
-
Production and Stabilization of Specific Upregulated Long Noncoding RNA HOXD-AS2 in Glioblastomas Are Mediated by TFE3 and miR-661, Respectively.Int J Mol Sci. 2022 Mar 4;23(5):2828. doi: 10.3390/ijms23052828. Int J Mol Sci. 2022. PMID: 35269968 Free PMC article.
References
-
- Costa PM, Cardoso A, Mano M, et al. MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies. CNS Neurol Disord Drug Targets. 2015;14(2):222–238. - PubMed
-
- Mercer TR, Mattick JS.. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300–307. - PubMed
-
- Thrash-Bingham CA, Tartof KD.. aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst. 1999;91(2):143–151. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources